Senator Seidman: The Tobacco and Vaping Products Act amended the Tobacco Act to add a new and separate class of products, vaping products, for which there was little scientific evidence available about the harms and benefits. We did not know if vaping was effective for smoking cessation. We did not know the harms of vaping flavours, and we did not know the overall effect of vaping as a gateway to tobacco use for youth. That is why the requirement that a legislative review be conducted is of critical importance. It allows parliamentarians to update this innovative health legislation as the science evolves, to address potential unintended consequences.

Senator Gold, how can we ensure that this important legislative review is completed, and the report is tabled here in the Senate and in the other place as soon as possible?